There is limited information about trends in the treatment of opioid use disorder (OUD) among Medicaid enrollees. This study from HIP Investigator Dr. Marguerite Burns aimed to examine the use of medications for OUD and potential indicators of quality of care in multiple states.
In this exploratory serial cross-sectional study using data from 1,024,301 Medicaid enrollees in 11 states, the prevalence of medication treatment for OUD increased from 47.8% in 2014 to 57.1% in 2018. There was substantial variation across and within states in any use and continuity (for 180 days) of medications for OUD by age, race/ethnicity, eligibility group, behavioral health comorbidity, and rural vs urban residence.
Read More